When should we treat moderate hypoxaemia in patients with COPD?
- PMID: 36332642
- DOI: 10.1016/S2213-2600(22)00355-1
When should we treat moderate hypoxaemia in patients with COPD?
Conflict of interest statement
PH reports grants from the National Institutes of Health, outside of the submitted work. AA declares no competing interests.
Comment in
-
When should we treat moderate hypoxaemia in patients with COPD? - Authors' reply.Lancet Respir Med. 2022 Nov;10(11):e98. doi: 10.1016/S2213-2600(22)00357-5. Lancet Respir Med. 2022. PMID: 36332643 No abstract available.
Comment on
-
Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis.Lancet Respir Med. 2022 Nov;10(11):1029-1037. doi: 10.1016/S2213-2600(22)00179-5. Epub 2022 Jul 8. Lancet Respir Med. 2022. PMID: 35817074
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
